Anson Funds Management’s InspireMD, Inc. Series B Warrants NSPRZ Stock Holding History

Anson Funds Management’s Portfolio NSPRZ Stock Details NSPRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-250,000	Closed	-$85K	–	349
2020 Q4	$85K	Buy	+250,000	New	+$3.2K	0.02%	166
2019 Q4	–	Sell	-250,000	Closed	-$325	–	93
2019 Q3	$325	Hold	250,000	–	–	0.24%	28
2019 Q2	$853	Hold	250,000	–	–	0.41%	17
2019 Q1	$35K	Hold	250,000	–	–	0.02%	30
2018 Q4	$40K	Hold	250,000	–	–	0.02%	53
2018 Q3	$55K	Hold	250,000	–	–	0.02%	15
2018 Q2	$62K	Hold	250,000	–	–	0.04%	24
2018 Q1	$260K	Hold	250,000	–	–	0.19%	24
2017 Q4	$32K	Hold	250,000	–	–	0.02%	57
2017 Q3	$100K	Buy	+250,000	New	+$21.3K	0.02%	52

Other funds holding NSPRZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Anson Funds Management's NSPRZ Position: Q1 2021 in Review

Anson Funds Management sold out of InspireMD, Inc. Series B Warrants (NSPRZ) in Q1 2021, closing a stake of 250,000 shares — an estimated $85K sold.

Anson Funds Management first reported a position in NSPRZ in Q3 2017 and held it in 10 quarters. The position peaked at $260K in Q1 2018. 4 funds tracked by Wall St. Rank hold NSPRZ as of Q1 2021.

Anson Funds Management reported no remaining InspireMD, Inc. Series B Warrants position as of Q1 2021 after selling out during the quarter.
Anson Funds Management sold 250,000 InspireMD, Inc. Series B Warrants shares in Q1 2021, an estimated $85K.
Anson Funds Management first reported a position in InspireMD, Inc. Series B Warrants in Q3 2017 and held it in 10 quarters.
Anson Funds Management's InspireMD, Inc. Series B Warrants position peaked at $260K in Q1 2018.
4 funds tracked by Wall St. Rank held InspireMD, Inc. Series B Warrants as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.